These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 31419296)

  • 21. The acquisition of long-lived memory B cell responses to merozoite surface protein-8 in individuals with Plasmodium vivax infection.
    Kochayoo P; Kittisenachai N; Changrob S; Wangriatisak K; Muh F; Chootong P; Han ET
    Malar J; 2019 May; 18(1):188. PubMed ID: 31151441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B cell epitope mapping and characterization of naturally acquired antibodies to the Plasmodium vivax merozoite surface protein-3α (PvMSP-3α) in malaria exposed individuals from Brazilian Amazon.
    Lima-Junior JC; Jiang J; Rodrigues-da-Silva RN; Banic DM; Tran TM; Ribeiro RY; Meyer VS; De-Simone SG; Santos F; Moreno A; Barnwell JW; Galinski MR; Oliveira-Ferreira J
    Vaccine; 2011 Feb; 29(9):1801-11. PubMed ID: 21215342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal study of naturally acquired humoral immune responses against the merozoite surface protein 1 of Plasmodium vivax in patients from Rondonia, Brazil.
    Mertens F; Levitus G; Camargo LM; Ferreira MU; Dutra AP; Del Portillo HA
    Am J Trop Med Hyg; 1993 Sep; 49(3):383-92. PubMed ID: 8372960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acquisition of antibodies to merozoite surface protein 3 among residents of Korogwe, north eastern Tanzania.
    Segeja MD; Mmbando BP; Seth MD; Lusingu JP; Lemnge MM
    BMC Infect Dis; 2010 Mar; 10():55. PubMed ID: 20205959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of IgG reactivities to Plasmodium vivax merozoite invasion antigens in a Brazilian Amazon population.
    Tran TM; Oliveira-Ferreira J; Moreno A; Santos F; Yazdani SS; Chitnis CE; Altman JD; Meyer EV; Barnwell JW; Galinski MR
    Am J Trop Med Hyg; 2005 Aug; 73(2):244-55. PubMed ID: 16103583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The persistence of naturally acquired antibodies and memory B cells specific to rhoptry proteins of Plasmodium vivax in patients from areas of low malaria transmission.
    Kochayoo P; Changrob S; Wangriatisak K; Lee SK; Chootong P; Han ET
    Malar J; 2019 Nov; 18(1):382. PubMed ID: 31783870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Library of Plasmodium vivax Recombinant Merozoite Proteins Reveals New Vaccine Candidates and Protein-Protein Interactions.
    Hostetler JB; Sharma S; Bartholdson SJ; Wright GJ; Fairhurst RM; Rayner JC
    PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004264. PubMed ID: 26701602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sparse serological evidence of Plasmodium vivax transmission in the Ouest and Sud-Est departments of Haiti.
    Weppelmann TA; von Fricken ME; Lam B; Telisma T; Existe A; Lemoine JF; Larkin J; Okech BA
    Acta Trop; 2016 Oct; 162():27-34. PubMed ID: 27230796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Naturally Acquired Binding-Inhibitory Antibodies to Plasmodium vivax Duffy Binding Protein and Clinical Immunity to Malaria in Rural Amazonians.
    Nicolete VC; Frischmann S; Barbosa S; King CL; Ferreira MU
    J Infect Dis; 2016 Nov; 214(10):1539-1546. PubMed ID: 27578850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenetic markers associated with a naturally acquired humoral immune response against an N-terminal antigen of Plasmodium vivax merozoite surface protein 1 (PvMSP-1).
    Cassiano GC; Furini AA; Capobianco MP; Storti-Melo LM; Almeida ME; Barbosa DR; Póvoa MM; Nogueira PA; Machado RL
    Malar J; 2016 Jun; 15():306. PubMed ID: 27255376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and characterization of Pv50, a novel Plasmodium vivax merozoite surface protein.
    Cheng Y; Wang B; Lu F; Ahmed MA; Han JH; Na SH; Ha KS; Park WS; Hong SH; Han ET
    Parasit Vectors; 2019 Apr; 12(1):176. PubMed ID: 30999945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity of Plasmodium vivax combination subunit vaccine formulated with human compatible adjuvants in mice.
    Devi YS; Mukherjee P; Yazdani SS; Shakri AR; Mazumdar S; Pandey S; Chitnis CE; Chauhan VS
    Vaccine; 2007 Jul; 25(28):5166-74. PubMed ID: 17544179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contribution of Functional Antimalarial Immunity to Measures of Parasite Clearance in Therapeutic Efficacy Studies of Artemisinin Derivatives.
    O'Flaherty K; Ataíde R; Zaloumis SG; Ashley EA; Powell R; Feng G; Reiling L; Dondorp AM; Day NP; Dhorda M; Fairhurst RM; Lim P; Amaratunga C; Pukrittayakamee S; Hien TT; Htut Y; Mayxay M; Faiz MA; Beeson JG; Nosten F; Simpson JA; White NJ; Fowkes FJI
    J Infect Dis; 2019 Aug; 220(7):1178-1187. PubMed ID: 31075171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting a Reticulocyte Binding Protein and Duffy Binding Protein to Inhibit Reticulocyte Invasion by Plasmodium vivax.
    Gupta S; Singh S; Popovici J; Roesch C; Shakri AR; Guillotte-Blisnick M; Huon C; Menard D; Chitnis CE
    Sci Rep; 2018 Jul; 8(1):10511. PubMed ID: 30002416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using serological measures to monitor changes in malaria transmission in Vanuatu.
    Cook J; Reid H; Iavro J; Kuwahata M; Taleo G; Clements A; McCarthy J; Vallely A; Drakeley C
    Malar J; 2010 Jun; 9():169. PubMed ID: 20553604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IgG subclasses pattern and high-avidity antibody to the C-terminal region of merozoite surface protein 1 of Plasmodium vivax in an unstable hypoendemic region in Iran.
    Mehrizi AA; Zakeri S; Salmanian AH; Sanati MH; Djadid ND
    Acta Trop; 2009 Oct; 112(1):1-7. PubMed ID: 19481997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human IgG responses against the N-terminal region of the Merozoite Surface Protein 1 of Plasmodium vivax.
    del Portillo HA; Levitus G; Camargo LM; Ferreira MU; Mertens F
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():77-84. PubMed ID: 1343729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Main B-cell epitopes of PvAMA-1 and PvMSP-9 are targeted by naturally acquired antibodies and epitope-specific memory cells in acute and convalescent phases of vivax malaria.
    Soares RR; Nakaie CR; Rodrigues-da-Silva RN; da Silva RL; Lima-Junior JDC; Scopel KKG
    Parasite Immunol; 2020 May; 42(5):e12705. PubMed ID: 32096238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of naturally acquired immune responses against novel pre-erythrocytic Plasmodium vivax proteins in a low endemic malaria population located in the Peruvian Amazon Basin.
    Ventocilla JA; Tapia LL; Ponce R; Franco A; Leelawong M; Aguiar JC; Baldeviano GC; Wilder BK
    Malar J; 2024 May; 23(1):163. PubMed ID: 38783317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody responses to Plasmodium vivax Duffy binding and Erythrocyte binding proteins predict risk of infection and are associated with protection from clinical Malaria.
    He WQ; Shakri AR; Bhardwaj R; França CT; Stanisic DI; Healer J; Kiniboro B; Robinson LJ; Guillotte-Blisnick M; Huon C; Siba P; Cowman A; King CL; Tham WH; Chitnis CE; Mueller I
    PLoS Negl Trop Dis; 2019 Feb; 13(2):e0006987. PubMed ID: 30768655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.